Study of Biological Effect of Tarceva (OSI-774) for Patients Stricken by ENT Epidermoid Carcinoma
This study has been completed.
Sponsor:
Institut Claudius Regaud
Collaborator:
Hoffmann-La Roche
Information provided by:
Institut Claudius Regaud
ClinicalTrials.gov Identifier:
NCT00144976
First received: September 2, 2005
Last updated: May 9, 2008
Last verified: May 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | December 2006 |
| Primary Completion Date: | December 2006 (Final data collection date for primary outcome measure) |